Rachel King

Rachel K.
King was the founder of GlycoMimetics, Inc., founded in 2003, and served as Director from 2021 to 2025.
Current jobs include Independent Director at Novavax, Inc. since 2018, Director at MdBio, Inc., Director at University of Maryland Biopark, Director at Learning Undefeated, Inc., and Independent Director at Fulcrum Therapeutics, Inc. starting in 2024.
Former jobs include Chief Executive Officer at Genetic Therapy, Inc. from 1996 to 1998, President, Chief Executive Officer & Director at Biotechnology Innovation Organization from 2022 to 2024, Director at Warp Drive Bio, Inc., Executive Vice President at ALZA Corp., Senior Vice President at Novartis Corp.
from 1999 to 2001, Principal at Bain & Co., Inc., and Principal at NEA Management Co. LLC from 2009 to 2012.
Education includes undergraduate degree from Dartmouth College and MBAistration from Harvard Business School.